Aspirin remains one of the most inexpensive drugs in the pharmacy. A familiar brand name tablet costs less than 6 cents a pill. A bottle containing 300 tablets will set you back under $17. Despite the ...

CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

Low-dose daily aspirin in older adults lowers cancer risk in some, raises it in others, with one expert calling the research ...

Aspirin's role in preventing colorectal cancer is nuanced. While high-risk individuals, including those with unhealthy lifestyles or Lynch syndrome, may significantly benefit, its use carries risks ...

Low-dose aspirin may reduce risk for cancer development among older individuals with clonal hematopoiesis of indeterminate ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

A daily aspirin cuts cancer, but doctors say don't reach for the bottle yet. March 20, 2012— -- A daily aspirin may cut your risk of cancer, new research suggests. But doctors advise that there's ...

Scientists have described the “Eureka moment” when they discovered how aspirin may prevent some cancers from spreading. Their new research builds on existing evidence and suggests aspirin supports a ...

Just two aspirin a week may help reduce the risk of colorectal cancer in adults living unhealthy lifestyles, new research from Mass General Brigham finds. Nearly 108,000 health professionals were ...

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...

The use of low-dose aspirin among older people shows no effect in reducing the incidence of certain cancer types. However, the treatment — particularly with frequency of at least three times a week — ...

An innovative new study is trialing whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.